- Report
- October 2024
- 196 Pages
Global
From €3464EUR$3,545USD£2,892GBP
€3849EUR$3,939USD£3,213GBP
- Report
- August 2024
- 146 Pages
Global
From €3810EUR$3,899USD£3,180GBP
- Report
- April 2024
- 180 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- December 2023
- 146 Pages
Global
From €4348EUR$4,450USD£3,630GBP
- Report
- January 2024
- 200 Pages
Global
From €4055EUR$4,150USD£3,385GBP
- Report
- February 2023
- 140 Pages
Global
From €4689EUR$4,799USD£3,914GBP
- Report
- November 2023
- 190 Pages
Global
From €4397EUR$4,500USD£3,671GBP
- Report
- January 2022
- 115 Pages
Global
From €4641EUR$4,750USD£3,874GBP
- Report
- May 2023
- 140 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- May 2023
- 140 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- May 2023
- 147 Pages
Global
From €5861EUR$5,999USD£4,893GBP
- Report
- January 2024
- 94 Pages
Global
From €3500EUR$3,837USD£3,024GBP
- Report
- July 2022
- 288 Pages
Global
From €3488EUR$3,570USD£2,912GBP
The Viral Removal market within the context of Biotechnology is focused on the development of technologies and products that can detect, identify, and remove viruses from a variety of sources. This includes the development of diagnostic tests, vaccines, and treatments for viral infections. It also includes the development of technologies to detect and remove viruses from the environment, such as water, air, and food. These technologies are used to protect public health and safety, as well as to reduce the spread of infectious diseases.
The Viral Removal market is a rapidly growing sector of the biotechnology industry, with many companies investing in research and development to create new products and technologies. Companies in this market include AbbVie, Gilead Sciences, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more
